Partnerships

How We Work With Partners

The evidence infrastructure for cardiopulmonary mobility cannot be built by one organization. As a Texas Pulmonary Foundation initiative, TICM is structured for collaboration with sponsors, research teams, and funders who want more credible translational evidence in this field.

Texas Pulmonary Foundation501(c)(3) nonprofit • EIN: 88-1594950

Partnership, Not Procurement

Every engagement starts with the evidence decision in front of you, then scopes the right study around it. No standard package. No sales process.

Sponsor Proof

What TICM Contributes to a Partnership

TICM helps partners define the next evidence decision, design a right-sized study, and produce outputs that support real next-step decisions across cardiopulmonary mobility development.

Protocol Development

Deliverable

A clinically grounded protocol framework tailored to your population, device, and implementation context.

Partner value

Partners get a study logic that reflects cardiopulmonary realities, not generic testing conditions.

Decision supported

Supports the decision of what should be tested first, in whom, and under which progression logic.

Pilot Study Design

Deliverable

A milestone-sized pilot structure with defined endpoints, timelines, and evidence objectives.

Partner value

Partners get a study designed for the next milestone rather than a larger trial than the technology can yet justify.

Decision supported

Supports the decision of whether the technology is ready for broader validation, payer discussion, or implementation planning.

Evidence Outputs for Next-Step Decisions

Deliverable

Evidence summaries and study outputs oriented to regulatory, payer, clinical, and implementation questions.

Partner value

Partners get findings that help move the technology forward beyond publication alone.

Decision supported

Supports the decision of what the next regulatory, reimbursement, adoption, or development step should be.

Process

How an Engagement Works

Every engagement follows the same arc: understand the evidence decision, scope the study, execute it, and deliver outputs that travel beyond publication.

01

Evaluate Fit

A conversation about where your technology or research question stands and what evidence decision comes next.

02

Scope the Study

Define the endpoints, populations, timeline, and outputs required for your specific milestone.

03

Execute

TICM conducts the study within active clinical settings, with direct patient access from day one.

04

Evidence Package

Outputs designed to travel: peer review, regulatory submission, payer evaluation, and clinical adoption.

Pathways

Areas of Collaboration

TICM partners across four areas, each shaped by the specific evidence needs of the technologies and organizations involved.

Early-Stage Feasibility

For technologies entering clinical validation, connecting emerging devices with the cardiopulmonary and mobility populations most relevant to their clinical thesis. Designed to generate initial evidence that informs the next stage of development.

Functional & Cardiopulmonary Validation

Studies anchored in functional and physiologic endpoints designed to support not just publication, but regulatory, payer, and adoption decisions. The endpoints are selected for where the evidence needs to go, not just where the study begins.

Evidence Strategy & Design

Mapping the evidence journey before a study begins: which questions to answer first, which endpoints to prioritize, and how each study builds toward a coherent body of evidence rather than a set of isolated results.

Research Collaboration

Joint investigation with academic and clinical partners on shared scientific questions, advancing understanding of how patients move, breathe, and recover in the context of cardiopulmonary mobility.
Explore collaboration
Partners

Who We Work With

Device & Robotics Companies

Wearable robotics, exoskeleton, and assistive mobility device developers seeking clinical evidence for their technologies.

Digital Health Companies

Physiologic monitoring, respiratory wearable, and remote patient monitoring companies needing clinical validation.

Academic Collaborators

Research teams and institutions pursuing shared scientific questions in cardiopulmonary mobility.

Funders & Foundations

Grant-making organizations and philanthropic funders supporting translational research in rehabilitation and mobility.

Health Systems

Health systems and rehabilitation networks interested in evidence-informed integration of mobility technologies.

Government & Policy

Agencies and programs advancing evidence standards for mobility, rehabilitation, and cardiopulmonary care.

Get in Touch

Discuss a Pilot or Partnership

Tell us where your technology, pilot question, or evidence need stands today. We'll respond within 48 hours with the right next conversation.

You can also reach TICM directly at research@txpulmfoundation.org for research and partnership inquiries.

We respond to all inquiries within 2 business days.

What to expect

  • No sales process

    Every conversation starts with your evidence question, not a pitch deck.

  • Starts where you are

    We meet you at your current stage: early feasibility, validation, or strategy.

  • Response within 48 hours

    All partnership inquiries receive a direct response from the institute.

The Institute for Cardiopulmonary Mobility

A 501(c)(3) nonprofit research institute generating clinical evidence for cardiopulmonary mobility technologies.